100 - Biological Response and Clinical Benefit to Azacitidine Versus Best Supportive Care in Adult Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) Who-2016 Classification
| Autor: | Hernández Mohedo, F.M., Falantes González, J., Sanchez García, J., Medina Pérez, A., Expósito Ruiz, M., Mesa Morales, Z., Jurado Chacón, M. |
|---|---|
| Zdroj: | In Leukemia Research April 2017 55 Supplement 1:S63-S63 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect